The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The wellness world is eager for RFK Jr.'s promised move on peptides : NPR The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Banned: Key Facts on the Latest FDA Decision BPC 157: Miracle Healing Peptide or Hidden Danger? The FDA is reviewing 12 peptides for removal from its restricted listincluding BPC 157, TB 500, Semax, and GHK Cu. If it goes through, it's the biggest peptide policy shift in years. More access. Easier